logo
Asian women called ‘divas' by NHS staff when asking for pain relief

Asian women called ‘divas' by NHS staff when asking for pain relief

The Health Secretary said he was determined to deal with inequalities and racism in the health service as he launched a national investigation into NHS maternity services.
He pointed to data showing that babies of black ethnicity are twice as likely to be stillborn than babies of white ethnicity, and black women are two to three times more likely to die during pregnancy or shortly after birth than white women.
He said he had been 'stunned' by language used against black and Asian mothers in maternity and neonatal units.
'We've got a lot of work to do not just on health inequalities, but on racism and discrimination in maternity care,' he said.
'I've been really stunned by some of the language that women have heard during the course of their own care: one mother saying that she'd been denied pain relief medication because they thought she was a 'strong black woman', another describing Asian mothers referred to as 'divas' when they asked for pain relief.
'I'm almost sat there in a state of disbelief, because what you hear is so shocking, you think this can't possibly be true.
'And then you look at the evidence, and you see that what they have been through, is exactly as they describe.'
The national investigation will look at all aspects of maternity care in England after several high-profile scandals found hundreds of babies have died or been left disabled due to poor care.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warwickshire adults struggling with NHS ADHD referral pause
Warwickshire adults struggling with NHS ADHD referral pause

BBC News

timean hour ago

  • BBC News

Warwickshire adults struggling with NHS ADHD referral pause

People who believe they have attention deficit hyperactivity disorder (ADHD) have said they feel ''absolutely devastated'' after finding out they cannot get a referral for assessment on the NHS. The Coventry and Warwickshire Partnership NHS Trust temporarily stopped accepting new referrals for adults over the age of 25 last month, in an effort to cut waiting lists for Myers, 32, from Coventry, said he had been to his GP to try and get a diagnosis, however he was told he was three weeks too late. The NHS trust said it was committed to bringing back adult referrals "as soon as possible". Mr Myers, who believes having a diagnosis would help him get access to the right support and medication, said: "I was absolutely devastated.''I think it would have a massive impact on the quality of my life."He added that he often found it difficult to concentrate and struggled to stay focused at work. "It has affected my life for as long as I can remember," he said.''ADHD assessments matter, not just for children. I understand that it's going to take priority, but if we got missed as a child, why should we not have the opportunity to get that diagnosis now," Mr Myers said. Dr Imogen Staveley, chief medical officer for Coventry & Warwickshire Integrated Care Board (ICB), said the suspension had been put in place as the diagnosis pathway was "not working for anyone" and children were the "most disadvantaged"."We've got about 7,500 children on the waiting list and some of those children are waiting up to 10 years to receive a diagnosis," Dr Staveley said long waiting times had resulted from how demand for diagnoses had "really increased" over the years and services "just hadn't kept up".Dr Staveley added that the temporary policy would enable the ICB to work with partners, such as local councils, to "redesign the pathway". Kerry Anne Hartnett thought living with undiagnosed ADHD had affected her whole life. "Time management is a massive problem for me," the 40-year-old from Coventry said, "I can't be on time for anything and I've almost had disciplinary action taken against me at work in the past because of it."Ms Hartnett recently visited her GP to try and get a diagnosis but was told the suspension meant it was not added that she also struggled with everyday tasks and even going to a supermarket could be overwhelming. "I find it so stressful and that's been a feature throughout my life. I've ended up having to have a lot of time off work, sick, due to stress." 'We don't matter' A 32-year-old woman, who did not want to be identified, told the BBC the suspension led to her mental health "deteriorating even further".She was diagnosed with ADHD in South Africa, before she moved to the UK, but said she was now unable to get a referral to access the medication she needed. ''It was so devastating, I burst into tears when I found out,'' said the woman who lives in Warwickshire. She understood that the children's waiting lists needed to be tackled, but said she felt the decision sent a message to adults that ''we don't matter''. Dr Staveley said support was available outside of a diagnosis and advised those who were waiting to speak to their chief medical officer said the ICB "did not have a time frame" for when the services would resume, however the pause was "temporary" and "meant to be short-lived".''We are committed to introducing this new pathway as soon as possible," she added. Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and Instagram.

Dr Amir Khan shares warning about sepsis as he lists symptoms to look for
Dr Amir Khan shares warning about sepsis as he lists symptoms to look for

Daily Mirror

timean hour ago

  • Daily Mirror

Dr Amir Khan shares warning about sepsis as he lists symptoms to look for

NHS doctor Amir Khan is urging people to look out for seven warning signs and symptoms of sepsis as it's important to catch it and start treatment early to avoid serious complications Sepsis is a condition that many people most likely will have heard of at some point in their life. However, many might not realise just how dangerous it can be. Sepsis a life-threatening condition that's happens when the body's response to infection ends up attacking its own tissues and organs, with the immune system going into overdrive. The UK Sepsis Trust reports 245,000 cases and 48,000 deaths annually in the UK. That's around four people dying every hour. It's a leading cause of death, surpassing some cancers, and a significant portion of cases are preventable with timely diagnosis and treatment. Many of these cases could be prevented with early diagnosis and treatment. ‌ In order to help boost public understanding of sepsis and help spot early signs, NHS GP Dr Amir Khan, known for appearing on ITV shows such as Lorraine, took to social media to discussing what sepsis does to the body and outline share warning signs everyone should look out for. ‌ "Let's talk about sepsis," medical exper t Dr Khan said at the start of the video. "Now sepsis occurs when your immune system has a dangerous reaction to an infection. Now, normally when you have an infection, your immune system works to try to fight it." However, sometimes your immune system stops fighting the infection and starts damaging your tissues and organs, leading to widespread inflammation throughout your body. At the same time, an abnormal chain reaction in your clotting system can cause blood clots to form in your blood vessels. "This reduces blood flow to different parts of your body and causes significant damage or even organ failure," he explained. "It can happen as a result of any type of infection." He went on to say: "The people who are most at risk of sepsis are those aged over 65, newborns and infants, pregnant women, those with underlying medical conditions and weakened immune systems, and anyone with things like catheters or tubes in place." ‌ Symptoms of sepsis So what are the symptoms of sepsis? Dr Khan went on to share seven signs you should look out for. "Symptoms of sepsis include weakness and fatigue, a fast heart rate, low blood pressure, a very high or very low temperature, shaking and chills, cold clammy skin, and pain," he shared. According to the NHS, other signs may include pale, blotchy, or blue skin, lips, or tongue, a rash that doesn't fade when pressed, difficulty breathing, and feeling very hot or cold. "Now, sepsis is a medical emergency and if you think anyone is suffering from sepsis, get prompt medical advice," Dr Khan said. "The quicker you seek treatment, the better their outcome will be." If a baby or a young child shows signs of sepsis, the NHS advises you to call 999 or visit A&E immediately. This advice also applies if an adult or older child exhibits symptoms such as confusion, slurred speech, skin that is blue, grey, pale or blotchy, lips or tongue, a rash that doesn't fade when a glass is rolled over it, or experiences difficulty breathing, breathlessness or rapid breathing. If you or someone else is showing signs of sepsis, the NHS recommends calling 111 for guidance on what to do next.

Mounjaro weight loss jabs now available at GPs in England
Mounjaro weight loss jabs now available at GPs in England

ITV News

timean hour ago

  • ITV News

Mounjaro weight loss jabs now available at GPs in England

Thousands of patients in England will be able to access weight loss jabs via their GP from Monday as they are allowed to prescribe the drugs for the first time. Around 220,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years. The drug is an antidiabetic medication that lowers blood sugar levels and slows down the rate of food digestion. From Monday, GPs in England will be allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health problems. Patients previously needed to access the drugs through a special weight loss service. But leading family doctors said some GPs have expressed concern about the additional workload linked to the rollout. And pharmacy experts also said there could be pressure on supplies of the drug. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes, high blood pressure, heart disease, and obstructive sleep apnoea. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. Dr Claire Fuller, from NHS England, said: 'This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today. 'We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health – and greater access to weight loss drugs will make a significant difference to the lives of those people. 'These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity, which will be vital in helping some people lose weight and reduce their risk of serious long-term conditions. 'While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'While we recognise the potential benefits of weight loss drugs, we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments. 'The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss. As and when this is escalated, appropriate resourcing for general practice – including access to 'wraparound' services – and training for GPs must follow. She added: 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely. 'More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. 'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.' Dr Hawthorne said there is no 'one size fits all approach' and that the rollout of the jabs should not 'come at the expense of other weight loss service'. She continued: 'The roll-out of weight loss medications in the NHS will need to be consistently evaluated to ensure that there is evidence that these prescriptions are of long-term benefit to patients.' Olivier Picard, chairman of the National Pharmacy Association, said: 'The demand for weight loss jabs continues to rise sharply, and more GPs have been directing patients back to pharmacies after initial inquiries, to access these treatments privately. 'As the NHS is now moving to implement National Institute for Health and Care Excellence (Nice) guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly. 'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy. 'Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice. 'We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it. 'The biggest concern we have is that prescribing these medications alone misses the point. 'They should be part of a comprehensive weight management strategy – combining lifestyle coaching, exercise, and nutritional guidance. In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up. 'As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends – simply because the foundational lifestyle changes weren't addressed.' But critics have claimed millions of people eligible for the treatment under the NHS criteria will miss out. Around 29% of the adult population in the UK is obese but less than 1% will get access to the drug in the initial phase. CEO of private health provider CheqUp, Toby Nicol, said: 'Obesity sits at the very heart of so many of our health and societal problems that the government should make it a priority to eradicate obesity and, for the first time, medications are available to make that happen. "The NHS should be providing this medication to as many people as is needed.' Health Secretary Wes Streeting said: 'Obesity is now one of the leading causes of ill health, costing the NHS billions. Yet we now have the science, technology, and knowledge to end the obesity epidemic, if we seize this opportunity. 'Obesity jabs are used by 1.5 million people in the UK, mainly through private prescriptions. The NHS was founded on a promise to 'universalise the best', and this Government is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay. 'This rollout is an important step in making these medicines more widely available, and beginning to shift the focus of healthcare from sickness to prevention, which our forthcoming 10-year plan will deliver.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store